Multiple primary malignancies in 788 Chinese patients with diffuse large B-cell lymphoma

Area of Science:

• Hematology
• Oncology
• Cancer Epidemiology

Background:

• Diffuse large B-cell lymphoma (DLBCL) is the most prevalent non-Hodgkin lymphoma globally.
• Multiple primary malignancies (MPMs) are increasingly recognized as a significant prognostic factor in various cancers.
• Understanding MPM in DLBCL is crucial for improving patient outcomes.

Purpose of the Study:

• To investigate the incidence, morbidity, and survival associated with MPM in DLBCL patients.
• To identify risk factors for developing MPM in DLBCL.
• To evaluate the prognostic significance of MPM in DLBCL.

Main Methods:

• Retrospective review of 788 DLBCL patient cases.
• Analysis of MPM diagnosis, including subsequent primary malignancies (SPM) via pathologic biopsy.
• Statistical analysis to identify prognostic factors for overall survival (OS).

Main Results:

• Forty-two patients (5.3%) were diagnosed with MPM; 22 had SPM.
• SPM incidence correlated with older age.
• Germinal center B-cell-like (GCB) subtype and earlier Ann Arbor stage were associated with higher SPM risk.
• MPM, age, LDH, ECOG PS, Hans classification, and IPI score were significant prognostic factors for OS.

Conclusions:

• MPM represents a comprehensive prognostic factor in DLBCL.
• MPM is an independent prognostic factor for DLBCL survival in univariate analysis.
• These findings offer insights into MPM's role in DLBCL patient management.